BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hesperos Inc. - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hesperos Inc.
X-ORIGINAL-URL:https://hesperosinc.com
X-WR-CALDESC:Events for Hesperos Inc.
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20260308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20261101T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20270314T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20271107T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260427
DTEND;VALUE=DATE:20260429
DTSTAMP:20260515T134811
CREATED:20260427T163409Z
LAST-MODIFIED:20260427T163409Z
UID:3712-1777248000-1777420799@hesperosinc.com
SUMMARY:Hesperos Presenting at Stanford Drug Discovery Symposium 2026
DESCRIPTION:Hesperos\, Inc. is excited to announce that our Chief Scientist\, James J. Hickman\, Ph.D.\, and Senior Scientist\, Kaveena Autar\, PhD\, are attending the Stanford Drug Discovery Symposium (SDDS 2026). This premier event brings together leading researchers\, industry professionals\, and innovators to discuss the latest breakthroughs and technologies in drug development. \nPoster Presentation: “In Vitro to In Vivo Translatability of Functional Human-on-a-Chip Systems for Digital Twin Modeling” \nKaveena will present Poster #10 that describes how Hesperos’ Human-on-a-Chip® (HoaC) single and multi-organ system platform models bridge the translational gap between preclinical discovery and predicted clinical outcomes to de-risk and accelerate development pipelines in a cost-effective manner. The research describes how integration of the HoaC platform models with advanced\, in silico\, pharmacokinetic/pharmacodynamic (PK/PD) digital twin modeling can better predict clinical dosing strategies from in vitro readouts. The poster showcases two compelling case studies: (1) an assessment of neurocognitive functional rescue using one of our CNS models and\, (2) accurate predictions of clinical dosing regimens using our multi-organ Malaria-on-a-Chip model. \nAbout our Team\nJames J. Hickman\, Ph.D.\, is Co-Founder and Chief Scientist at Hesperos\, Inc. He also is the Founding Director of the NanoScience Technology Center at the University of Central Florida. A pioneer in the MPS field\, Dr. Hickman\, has spent over 30 years developing functional in vitro systems. He is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE)\, the National Academy of Inventors\, and is the President of the International Microphysiological Systems Society (IMPSS). \nKaveena Autar\, PhD is a Senior Scientist\, her research focuses on the translatability of functional in vitro systems\, with particular emphasis on advanced neuronal studies. She has developed phenotypic models of human induced pluripotent stem cell (hiPSC)-derived cortical neurons to characterize network maturation and disease pathology. \nAttending SDDS 2026? We invite you to connect with J and Kaveena to discuss how Hesperos’ platform technology can support and accelerate your drug development programs in an expedient\, cost-effective manner.\n\nLink to the Full Program
URL:https://hesperosinc.com/event/hesperos-presenting-at-stanford-drug-discovery-symposium-2026/
LOCATION:Frances C. Arrillaga Alumni Center\, 326 Galvez St\, Stanford\, CA\, 94305\, United States
CATEGORIES:Poster Presentation
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/04/SDDS2026-Graphic.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260322
DTEND;VALUE=DATE:20260326
DTSTAMP:20260515T134811
CREATED:20260304T195539Z
LAST-MODIFIED:20260320T144307Z
UID:3539-1774137600-1774483199@hesperosinc.com
SUMMARY:Join Hesperos at Society of Toxicology (SOT) 2026: Booth #846
DESCRIPTION:Visit Hesperos at SOT 2026 ToxExpo: Booth #846\nStop by and take the opportunity to discuss how Hesperos’ single and multi-organ Human-on-a-Chip® organ system models can help your organization better elucidate and understand your product’s profile. \n\nFeatured Presentations\n \n\nPoster Presentation: \n#H624: The Utilization of In Vitro\, Human on a Chip Cortical Networks to Assess Neurocognitive Impairment for Drug Safety and Efficacy \n\nPresented by: Rocky Brighton\nTuesday\, March 24\, 9:15am – 11:45am PT\nView Session Details\n\n\nPoster Presentation: \n#F505: Off target toxicity and efficacy testing of a novel stress reliever in a multi-organ microphysiological system \n\nPresented by: Christopher McAleer\, PhD\nWednesday\, March 25\, 9:15am – 11:45am PT\nView Session Details\n\n\n\n\n  \nView Hesperos SOT Booth #846
URL:https://hesperosinc.com/event/hesperos-at-sot-2026-booth-846/
LOCATION:San Diego Convention Center
CATEGORIES:Exhibitor,Poster Presentation
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/03/SOT-Announcement-Graphic1200-x-700-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250316
DTEND;VALUE=DATE:20250321
DTSTAMP:20260515T134811
CREATED:20250124T184351Z
LAST-MODIFIED:20250317T203147Z
UID:2965-1742083200-1742515199@hesperosinc.com
SUMMARY:2025 Annual SOT Meeting and ToxExpo
DESCRIPTION:2025 Annual SOT Meeting and ToxExpo \nMarch 16-20\, 2025 \nOrlando\, FL \nHesperos Panel Chair \nJ. Hickman\, PhD\, co-chair \nNext generation of in vitro neurotoxicology – modeling cognition-in-a-dish \nMarch 19\, 8:00 am \nHesperos at SOT 2025 \nVisit us at Booth #1071 in the ToxExpo Hall! \nHesperos Posters \nJ. Hickman\, PhD: #L609 \nDifferential Metabolism in Microphysiological Systems for Evaluation of Efficacy and Off-target Toxicity for the NK-1 Antagonist Tradipitant \nMarch 19\, 9:15-11:45 am \nKaveena Autar\, PhD: #P745 \nThe Utilization of In Vitro\, Human-on-a-Chip® Cortical Networks to Assess Neurocognitive Impairment for Drug Safety and Efficacy \nMarch 18\, 9:15-11:45 am \nMridu Malik\, PhD:#K569 \nOff-target toxicity and efficacy testing of a novel stress reliever in a multi-organ microphysiological system \nMarch 19\, 9:15-11:45 am \nWalker Hagan\, PhD: #K571 \nA Human-on-a-Chip® neuromuscular junction model for the evaluation of botulinum neurotoxin potency \nMarch 19\, 9:15-11:45 am \nMichael Jakob Rupar: #K565 \nSafety Assessment of Antimalarial Therapeutic Delivery in a Human-Based Malaria-on-a-Chip® Phenotypic Disease Model \nMarch 19\, 9:15-11:45 am \nAbout the 2025 Annual SOT Meeting and ToxExpo: Hosted by the Society of Toxicology at the Orange County Convention Center in Orlando\, this event brings together experts in the field of toxicology for five days of scientific sessions\, poster presentations\, and networking events. \nLearn more and register at: https://www.toxicology.org/events/am/AM2025/index.asp#
URL:https://hesperosinc.com/event/2025-annual-sot-meeting-and-toxexpo/
LOCATION:Orange County Convention Center
CATEGORIES:Exhibitor,Poster Presentation
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/01/SOT-social.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241113
DTEND;VALUE=DATE:20241117
DTSTAMP:20260515T134811
CREATED:20241030T134054Z
LAST-MODIFIED:20241114T150409Z
UID:2775-1731456000-1731801599@hesperosinc.com
SUMMARY:GSA 2024 Annual Scientific Meeting
DESCRIPTION:GSA 2024 Annual Scientific Meeting \nPoster Presentation \nKaveena Autar\, PhD \nPoster #270 \n“Investigating Drug-Induced Dementia in a CNS MPS Assessing Deficits in LTP From Anticholinergic Cognitive Burden” \nNov. 15\, 2:00-3:15 PST \nAbout GSA:  GSA 2024\, organized by the Gerontological Society of America\, is a premier annual scientific meeting for cutting-edge scholarship\, research\, and networking relating to the fields of aging and gerontology.  GSA’s mission is to promote the study of aging and disseminate information to scientists\, decision makers\, and the general public. Founded in 1945\, GSA is the driving force behind advancing innovation in aging — both domestically and internationally.  This year’s scientific meeting will be in Seattle\, WA\, Nov 13-16th. \nLearn more and register at https://www.gsa2024.org/ \nMake sure to stop by and see Dr. Autar if you’re there!
URL:https://hesperosinc.com/event/gsa-2024-annual-scientific-meeting/
LOCATION:Seattle Convention Center\, Seattle\, WA\, United States
CATEGORIES:Poster Presentation
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2024/10/Poster-Social-Post-Template-1280-x-600-px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240610
DTEND;VALUE=DATE:20240615
DTSTAMP:20260515T134811
CREATED:20241105T151402Z
LAST-MODIFIED:20241105T152717Z
UID:2854-1717977600-1718409599@hesperosinc.com
SUMMARY:MPS World Summit 2024
DESCRIPTION:MPS World Summit 2024 \nInvited Speaker \nJ. Hickman\, PhD\, Chief Scientist \n“Human-on-a-chip systems for use in neurological disease and aging research“ \nJune 11\, 2:30pm\, 320-322 \n  \nHesperos Presentations \nAkhmetzada Kargazhanov:  “Evaluating the neuromuscular pathology in Alzheimer’s disease from familial mutations by utilizing a human iPSC-derived in vitro functional NMJ model” \nJune 10\, 11:15 am\, 327 \nWilliam Bogen: “Design and implementation of a custom machine learning model for segmentation of electrophysiological cardiomyocyte responses in organ-on-a-chip applications” \nJune 12 3:40 pm\, 320-322 \nWalker Hagan\, PhD: “A Human-on-a-Chip® CMT2S model for the evaluation of personalized medicine” \nJune 12\, 4:00 pm\, 323-325 \nAakash Patel: “A multi-organ human-on-a-chip system modeling chronic opioid overdose rescue efficacy and off-target toxicity” \n June 13\, 1:00 pm\, Flex A \nMichael Jakob Rupar: “Implementation of a Human Cell-Based Malaria-on-a-Chip Phenotypic Disease Model for Drug Efficacy Evaluation” \nJune 14\, 12:10 pm\, 327-329 \nDallas Nash: “Investigation into the effect of APOE4 iPSC derived astrocytes on the blood brain barrier through in vitro models” \nJune 14\, 12:20 pm\, 320-322 \n  \nHesperos at MPS World Summit 2024 \nVisit us at Booth #3 in Summit Building Flex C! \n  \nHesperos Posters \nXiufang Guo\, PhD: #436 \nJune 11\, 10-11:30 am \nKenneth Hawkins: #562 \n June 11\, 10-11:30 am \nKaveena Autar\, PhD:#168 \nJune 11\, 4:30-6 pm \nMaria Grisales: #338 \nJune 11\, 4:30-6 pm \nZhanhe Liu\, PhD: #468 \nJune 11\, 4:30-6 pm \nJoseph Ciurca: #469 \nJune 12\, 10-11:30 am \nAakash Patel: #360  \nJune 13\, 10-11:30 am \nGabriel Kaatz: #589 \n June 13\, 4:30-6 pm \nAkhmetzada Kargzhanov: #653 \nJune 13\, 4:30-6 pm \nMridu Malik\, PhD: #502 \nJune 13\, 4:30-6 pm \nAbout MPS World Summit 2024: MPS World Summit is a gathering organized by the International Microphysiological Systems Society (IMPSS) for leaders in the MPS field to present the latest scientific achievements\, discuss the advances and challenges\, and educate young and newly interested scientists.  The 2024 Summit is the 4th annual MPS World Summit and will take place in Seattle\, WA. \nLearn more and register at https://mpsworldsummit.org/
URL:https://hesperosinc.com/event/mps-world-summit-2024/
LOCATION:Seattle Convention Center\, Seattle\, WA\, United States
CATEGORIES:Exhibitor,Invited Speaker,Poster Presentation
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2024/11/Event-Web-Page-Graphics-10.jpg
END:VEVENT
END:VCALENDAR